Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study

Md. Ismail Hosen(University of Dhaka), Florence Le Calvez‐Kelm(Centre international de recherche sur le cancer), Farin Kamangar(Department of Health and Human Services), Christian C. Abnet(National Institutes of Health), Mahdi Sheikh(Centre international de recherche sur le cancer), Paolo Boffetta(University of Bologna), Maria I. Zvereva(Lomonosov Moscow State University), Masoud Sotoudeh(Tehran University of Medical Sciences), Arash Etemadi(National Institutes of Health), Masoud Khoshnia(Shariati Hospital), Catherine Voegele(Centre international de recherche sur le cancer), Ghislaine Scélo(Observational & Pragmatic Research Institute), Priscilia Chopard(Centre international de recherche sur le cancer), Gholamreza Roshandel(Golestan University), Nathalie Forey(Centre international de recherche sur le cancer), Hossein Poustchi(Shariati Hospital), Tiffany M. Delhomme(Centre international de recherche sur le cancer), Arash Nikmanesh(Tehran University of Medical Sciences), Sanford M. Dawsey(National Cancer Institute), Patrice Hodonou Avogbe(Centre international de recherche sur le cancer), Geoffroy Durand(Centre international de recherche sur le cancer), Elisabete Weiderpass(Centre international de recherche sur le cancer), Matthieu Foll(Centre international de recherche sur le cancer), James McKay(Centre international de recherche sur le cancer), Reza Malekzadeh(Tehran University of Medical Sciences), Arnaud Manel(Infirmerie Protestante), Paul Brennan(Centre international de recherche sur le cancer), Paul D Pharaoh(University of Cambridge), E. Vian(Infirmerie Protestante)
EBioMedicine
February 17, 2020
Cited by 84


Related Papers